A detailed history of Royal Fund Management, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Royal Fund Management, LLC holds 27,027 shares of MDT stock, worth $2.6 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
27,027
Previous 27,448 1.53%
Holding current value
$2.6 Million
Previous $2.39 Million 7.61%
% of portfolio
0.32%
Previous 0.24%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

SELL
$87.67 - $95.74 $36,909 - $40,306
-421 Reduced 1.53%
27,027 $2.57 Million
Q2 2025

Aug 13, 2025

SELL
$80.68 - $88.86 $14,441 - $15,905
-179 Reduced 0.65%
27,448 $2.39 Million
Q1 2025

May 14, 2025

BUY
$79.84 - $94.5 $2.21 Million - $2.61 Million
27,627 New
27,627 $2.48 Million
Q2 2020

Aug 06, 2020

SELL
$84.11 - $103.33 $12,195 - $14,982
-145 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$72.92 - $121.3 $729 - $1,213
-10 Reduced 6.45%
145 $13,000
Q4 2019

May 11, 2020

SELL
$104.49 - $114.54 $2,089 - $2,290
-20 Reduced 11.43%
155 $17,000
Q3 2019

May 08, 2020

BUY
$98.02 - $111.18 $3,136 - $3,557
32 Added 22.38%
175 $18,000
Q2 2019

May 08, 2020

SELL
$84.15 - $99.38 $1,935 - $2,285
-23 Reduced 13.86%
143 $13,000
Q1 2019

May 11, 2020

BUY
$82.45 - $93.79 $989 - $1,125
12 Added 7.79%
166 $15,000
Q4 2018

May 07, 2020

BUY
$85.8 - $99.49 $943 - $1,094
11 Added 7.69%
154 $14,000
Q3 2018

May 07, 2020

SELL
$85.91 - $99.17 $28,865 - $33,321
-336 Reduced 70.15%
143 $14,000
Q2 2018

May 07, 2020

BUY
$77.48 - $87.83 $16,503 - $18,707
213 Added 80.08%
479 $41,000
Q1 2018

May 07, 2020

BUY
$76.55 - $87.26 $20,362 - $23,211
266 New
266 $21,000
Q3 2017

May 07, 2020

SELL
$77.71 - $84.6 $5,750 - $6,260
-74 Closed
0 $0
Q2 2017

May 07, 2020

BUY
N/A
74
74 $6,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $128B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Royal Fund Management, LLC Portfolio

Follow Royal Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.